In short: Reported: Silex (inventor of SILEX laser enrichment, 51% owner of GLE) announced the offtake. CEO Goldsworthy: it gives GLE's products a "home," guarantees Cameco-average pricing without GLE building sales/marketing, and "provides a key commercial pillar to support a future final investment decision (FID) for the PLEF," with customary terms protecting GLE and Silex.
Silex is the small Australian company that invented a way to enrich uranium with lasers instead of the giant spinning centrifuges everyone else uses. It owns 51% of Global Laser Enrichment, which is trying to turn the idea into a real plant in Kentucky.
The hardest part of financing a first-of-its-kind plant is proving someone will buy what it makes. This deal answers that: Cameco takes all of it and pays the same average price Cameco gets from its own long-term customers. Silex's CEO calls it a key pillar for the "final investment decision" — the formal go-ahead to spend the money to build. A US licence is expected in early 2027.
In short: 5% Focus List. The year's underperformance traces to being passed over in the DOE's LEU RFP — Centrus and General Matter took US$900M awards, Orano the sole LEU award, and 75%-owned GLE only US$28M. Huhn still "view[s] Silex/GLE favorably": TRL-6 achieved in 2025 de-risks the laser technology, TRL-7 is due mid-2027, and he "fully expect[s]" Cameco to exercise its option to lift GLE ownership from 25% to 51% before it expires in April 2028. The PLEF tails-reprocessing project at Paducah is "the equivalent of a 5M lb./yr. uranium 'mine'" at a cash cost under $30/lb, and the technology "provides a way for the West to free itself from" Russian conversion/enrichment dominance. −17.3% in June to A$5.30.
Silex is not a miner. It owns 75% of Global Laser Enrichment (GLE), which is developing a laser-based way to enrich uranium — separating the fissile isotope using tuned lasers instead of the spinning centrifuges everyone else uses. If it works at scale it is cheaper and less energy-hungry, and it matters strategically because Russia still dominates Western conversion and enrichment.
The share price lagged this year for a specific reason: the US Department of Energy handed out three US$900M contracts to build domestic enrichment capacity, and GLE was not one of them — Centrus and General Matter won those, Orano took the sole low-enriched-uranium award, and GLE got a consolation US$28M. The market wanted much more.
Huhn's case rests on two things the awards did not change. First, technical progress is gated on "TRL" milestones — a standard scale for how proven a technology is — and GLE hit TRL-6 in 2025, with TRL-7 due mid-2027. Cameco holds an option to raise its GLE stake from 25% to 51%, expiring April 2028, and Huhn "fully expect[s]" it to be exercised once TRL-7 lands: a large, informed buyer voting with money. Second is the Paducah project (PLEF), which would re-process roughly 150 million pounds of uranium sitting in old enrichment "tails" — waste from decades of past enrichment — back into usable fuel. That is effectively a 5-million-pound-a-year uranium mine with no mining, at a cash cost under $30 a pound, in Kentucky.
Full passage: premium transcript (PDF).
Nothing matches this filter.
Verbatim excerpts from the public transcripts (auto-pulled at each mention's timestamp, lightly cleaned). Timestamps link into the video; "source page" opens that commentator's full analysis at this row. Click a mention's header line to expand it (one open at a time). For personal study — not investment advice.